Loading…

Immunoglobulin Heavy Chain Gene Rearrangements in Patients with Gaucher Disease

Several studies support the evidence of increased incidence of hematological complications in Gaucher disease including monoclonal and polyclonal gammopathies and blood malignancies, especially multiple myeloma. Serum concentrations of immunoglobulins and PCR analysis of the IGH gene rearrangements...

Full description

Saved in:
Bibliographic Details
Published in:Journal of medical biochemistry 2018-07, Vol.37 (3), p.307-312
Main Authors: Rodić, Predrag, Lakočević, Milan, Pavlović, Sonja, Đurašević, Teodora Karan, Kostić, Tatjana, Vuković, Nada Suvajdžić, Šumarac, Zorica, Petakov, Milan, Janić, Dragana
Format: Article
Language:English
Subjects:
Citations: Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Several studies support the evidence of increased incidence of hematological complications in Gaucher disease including monoclonal and polyclonal gammopathies and blood malignancies, especially multiple myeloma. Serum concentrations of immunoglobulins and PCR analysis of the IGH gene rearrangements were performed. The clonal PCR products were directly sequenced and analyzed with the appropriate database and tools. Serum monoclonal proteins were detected and identified by electrophoresis. Among 27 Gaucher patients, clonal IGH rearrangement was discovered in eight, with 5/8 having also serum monoclonal protein. Elevated immunoglobulins were detected in 9/27 patients. Follow-up data for 17 patients showed that the clonal rearrangement remained the same in four of them, however, in one patient it disappeared after the follow-up period. The remaining 12/17 patients were without previous IGH clonal rearrangement and remained so after the follow-up. Although clonal expansion may occur relatively early in the disease course, at least judging by the IGH gene rearrangements in Gaucher patients, the detected clones may be transient. A careful clinical follow-up in these patients is mandatory, including monitoring for lymphoid neoplasms, especially multiple myeloma.
ISSN:1452-8258
1452-8266
1452-8266
DOI:10.1515/jomb-2017-0061